Its high debt load remained a cause of investor concern for the entire year, and as a result, CEO Albert Bourla’s turnaround ... Cramer’s remarks surrounded Dr. Bourla’s relationship and ...

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

While the exact date of the meeting was not disclosed, Bourla said he and the health secretary nominee chatted civilly, conversing on topics they agreed on rather than straying to more divisive ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Reports Q4 revenue $17.8B, consensus $17.26B. Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “2024 was a strong year of ...

Pfizer is cutting costs and refocussing its research and development (R&D) operations in a bid to maintain and grow revenues in 2025, says CEO Albert Bourla ... overseen by Dr. Chris Boshoff ...

But Pfizer (PFE) CEO Albert Bourla said he doesn't think so ... spurring opposition campaigns from doctor and science groups alike. Despite his past actions against the medical and science ...